Oct 7, 2026 08:00AM
Oct 5, 2026 08:00AM
Oct 1, 2026 08:00AM
Aug 18, 2026 08:00AM
Aug 11, 2026 08:00AM
Jul 29, 2026 08:00AM
Jul 27, 2026 08:00AM PharmaTher Launches Personaliz3D Peptides(TM) to Advance Personalized Peptide Care Following Positive FDA Advisory Committee Recommendations
Jul 21, 2026 08:02AM
Jul 21, 2026 08:00AM
Jul 15, 2026 08:00AM
May 27, 2026 08:00AM
May 13, 2026 10:11AM
May 13, 2026 08:50AM
Apr 21, 2026 08:00AM PharmaTher Highlights Strategic Ketamine Opportunity Following New U.S. Executive Order on Psychedelic Treatments for Serious Mental Illness
Apr 20, 2026 08:00AM
Apr 16, 2026 08:00AM
Apr 13, 2026 08:00AM
Mar 26, 2026 08:00AM
Mar 3, 2026 08:00AM
Feb 2, 2026 09:27AM
Jan 14, 2026 08:00AM PharmaTher Expands PharmaPatch(TM) Platform into GLP-1 for Obesity, Leveraging Its Ketamine and Psychedelic Patch Programs
Jan 2, 2026 08:00AM
Dec 2, 2025 09:53AM
Nov 17, 2025 08:00AM
Oct 17, 2025 08:26AM
Oct 16, 2025 08:04AM
Oct 16, 2025 08:00AM
Oct 15, 2025 08:00AM PharmaTher Announces KetAImine(TM) - AI Discovery Platform to Expand the Ketamine Portfolio, Enable Earlier Partnering, and Fast-Track 505(b)(2) NDA Filings
Oct 8, 2025 08:00AM
Aug 27, 2025 08:00AM
Aug 14, 2025 08:02AM
Aug 14, 2025 08:00AM
Aug 11, 2025 09:51AM
Aug 11, 2025 09:49AM
Mar 3, 2025 08:00AM PharmaTher Provides Complete Response Amendment for US FDA New Drug Application for Ketamine
Oct 31, 2024 08:58AM
Sep 19, 2024 08:00AM
Aug 28, 2024 08:00AM
Aug 21, 2024 09:52AM
Aug 19, 2024 08:00AM

471,922 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All